Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.2070
-0.0170 (-7.59%)
Oct 26, 2026, 1:46 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €9.27 million as of October 26, 2026. It is the 40,839th most valuable company in the world and the 103rd biggest in Belgium. Its market cap has decreased by 2.82% in one year.
Market Cap
9.27M
Enterprise Value
9.14M
Revenue
7.00K
Global Rank
Country Rank
#103 Belgium
PE Ratio
3.01
ChartMarket Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 9.27M, a decrease of -90.92%. That is a compound annual growth rate of -16.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 9.27M | 21.76% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 51.99B |
| argenx SE | 48.92B |
| Financière de Tubize | 9.82B |
| Onward Medical | 143.92M |
| Hyloris Pharmaceuticals | 110.32M |
| European Medical Solutions | 15.49M |
| BioSenic | 1.31M |
| Oxurion NV | 112.59K |